iPHONE 12

Oxford Covid Vaccine: Serum Institute Gets Nod For Phase 2, 3 Human Trial

The Drugs Controller General of India (DCGI) has given nod to the Serum Institute of India (SII) for conducting phase 2 and 3 human clinical trials of a COVID-19 vaccine candidate, developed by the...

Share:

No comments:

Post a Comment

amazon

Back to Top

Popular Posts

Blog Archive

Recent Posts